Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficient Synthesis of Novel Pyridine-Based Derivatives via Suzuki Cross-Coupling Reaction of Commercially Available 5-Bromo-2-methylpyridin-3-amine: Quantum Mechanical Investigations and Biological Activities.
Molecules. 2017 Jan 27;22(2):190. doi: 10.3390/molecules22020190.
Molecules. 2017.
PMID: 28134790
Free PMC article.
Facile green approach towards the synthesis of some phenyl piperazine based dithiocarbamates as potent hemolytic and thrombolytic agents.
Hafeez F, Mansha A, Fawad Zahoor A, Ghulam Ali K, Gul Khan S, Raza Naqvi SA.
Hafeez F, et al. Among authors: gul khan s.
Pak J Pharm Sci. 2021 Sep;34(5(Supplementary)):1885-1890.
Pak J Pharm Sci. 2021.
PMID: 34836855
Item in Clipboard
In-vitro cytotoxic evaluation of newly designed ciprofloxacin-oxadiazole hybrids against human liver tumor cell line (Huh7).
Akhtar R, Zahoor AF, Rasul A, Gul Khan S, Ali KG.
Akhtar R, et al. Among authors: gul khan s.
Pak J Pharm Sci. 2021 May;34(3(Supplementary)):1143-1148.
Pak J Pharm Sci. 2021.
PMID: 34602444
Item in Clipboard
In-silico modeling and in-vitro studies of 2,1-benzothiazine-2,2-dioxide based hydrazone derivatives as α-glucosidase inhibitors.
Ahmad S, Taj S, Aslam S, Gul Khan S, Farooq T, Ashfaq UA, Ahmad M.
Ahmad S, et al. Among authors: gul khan s.
Pak J Pharm Sci. 2021 Sep;34(5(Supplementary)):1951-1955.
Pak J Pharm Sci. 2021.
PMID: 34836865
Item in Clipboard
In-vitro cytotoxic evaluation, hemolytic and thrombolytic potential of newly designed acefylline based hydrazones as potent anticancer agents against human lung cancer cell line (A549).
Shahzadi I, Parveen B, Ahmad S, Gul Khan S, Zahoor AF, Rasul A, Zahid FM.
Shahzadi I, et al. Among authors: gul khan s.
Pak J Pharm Sci. 2022 May;35(3(Special)):885-889.
Pak J Pharm Sci. 2022.
PMID: 35791583
Item in Clipboard
Cite
Cite